← Leaderboards
William J Burlingham
University Of Wisconsin Madison
$9,912,734
Attributed
$9,912,734
Total exposure
10
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $775.8K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$9,912,734 · 10
By mechanism
R01$6,714,992 · 4
P01$1,784,129 · 1
R21$944,993 · 2
R56$251,970 · 1
K02$214,650 · 1
R13$2,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationImmune ResponseCellsResponseAutoimmunityHuman SubjectT-LymphocyteHeart TransplantationResistanceAntigensClinical ResearchEffector CellImmuneRegulatory T-LymphocyteChronicAlloantigenTissuesKidney TransplantationTransplant RecipientsMinorLung TransplantationImmunosuppressive AgentsBaseHeart Allograft
Grant awards (39)
Natural vs. Pathogenic Th17 responses to col Va1, Ka1tubulin and vimentin$376,140
R01 · FY2019 · AI · contact PI
Natural vs. Pathogenic Th17 responses to col Va1, Ka1tubulin and vimentin$376,140
R01 · FY2018 · AI · contact PI
Natural vs. Pathogenic Th17 responses to col Va1, Ka1tubulin and vimentin$376,140
R01 · FY2017 · AI · contact PI
Natural vs. Pathogenic Th17 responses to col Va1, Ka1tubulin and vimentin$367,175
R01 · FY2016 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$350,760
R01 · FY2016 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$332,541
R01 · FY2015 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$13,664
R01 · FY2015 · AI · contact PI
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation$375,306
P01 · FY2014 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$332,541
R01 · FY2014 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$312,588
R01 · FY2013 · AI · contact PI
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation$312,101
P01 · FY2013 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$391,828
R01 · FY2012 · AI · contact PI
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation$345,209
P01 · FY2012 · AI · contact PI
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation$367,373
P01 · FY2011 · AI · contact PI
Collagen a 1 (v) Epitope-Specific TH17 Cells in Heart and Lung Transplantation$384,140
P01 · FY2010 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$274,172
R01 · FY2010 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$107,413
R01 · FY2010 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$10,092
R01 · FY2010 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$277,032
R01 · FY2009 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$277,120
R01 · FY2008 · AI · contact PI
Minor H Antigen Regulatory Networks as an Alternative to Calcineurin Inhibitors i$215,853
R21 · FY2008 · DK · contact PI
Maternal Microchimerism and Neonatal Tolerance$282,574
R01 · FY2007 · AI · contact PI
Minor H Antigen Regulatory Networks as an Alternative to Calcineurin Inhibitors i$183,515
R21 · FY2007 · DK · contact PI
Maternal Microchimerism and Neonatal Tolerance$291,101
R01 · FY2006 · AI · contact PI
Maternal Microchimerism and Neonatal Tolerance$251,970
R56 · FY2005 · AI
IMMUNE REGULATION IN LUNG TRANSPLANTATION$288,000
R01 · FY2003 · AI
KIDNEY TRANSPLANTATION &NON-INHERITED MATERNAL ANTIGENS$220,123
R01 · FY2003 · AI
DONOR-DRIVEN REGULATION IN HUMAN ALLOGRAFT ACCEPTANCE$181,875
R21 · FY2003 · AI
IMMUNE REGULATION IN LUNG TRANSPLANTATION$259,200
R01 · FY2002 · AI
KIDNEY TRANSPLANTATION &NON-INHERITED MATERNAL ANTIGENS$213,712
R01 · FY2002 · AI
DONOR-DRIVEN REGULATION IN HUMAN ALLOGRAFT ACCEPTANCE$181,875
R21 · FY2002 · AI
IMMUNE REGULATION IN LUNG TRANSPLANTATION$288,000
R01 · FY2001 · AI
KIDNEY TRANSPLANTATION &NON-INHERITED MATERNAL ANTIGENS$207,490
R01 · FY2001 · AI
DONOR-DRIVEN REGULATION IN HUMAN ALLOGRAFT ACCEPTANCE$181,875
R21 · FY2001 · AI
SOLUBLE FORMS OF HLA-A B AND CHRONIC REJECTION$107,325
K02 · FY2001 · AI
IMMUNE REGULATION IN LUNG TRANSPLANTATION$288,000
R01 · FY2000 · AI
KIDNEY TRANSPLANTATION &NON-INHERITED MATERNAL ANTIGENS$201,446
R01 · FY2000 · AI
SOLUBLE FORMS OF HLA-A B AND CHRONIC REJECTION$107,325
K02 · FY2000 · AI
SOLUBLE MHC, IMMUNOREGULATION, AND TOLERANCE SYMPOSIUM$2,000
R13 · FY2000 · AI